| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| elapegademase | adenosine deaminase | NA | Successful target | TTD , DGIDB | Severe Combined Immunodeficiency[MeSHID:D016511] Disease[MeSHID:D004194] Severe combined immunodeficiency due to adenosine deaminase deficiency[MeSHID:C531816] Leukocytes[MeSHID:D007962] Hereditary Diseases[MeSHID:D030342] Mental Suffering[MeSHID:D013315] Malnutrition[MeSHID:D044342] Infection[MeSHID:D007239] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Immunologic Deficiency Syndromes[MeSHID:D007153] |
5.3 | approved | unknown |
| elapegademase | adenosine | biotech | NA | drugbank | Severe Combined Immunodeficiency[MeSHID:D016511] Disease[MeSHID:D004194] Severe combined immunodeficiency due to adenosine deaminase deficiency[MeSHID:C531816] Leukocytes[MeSHID:D007962] Hereditary Diseases[MeSHID:D030342] Mental Suffering[MeSHID:D013315] Malnutrition[MeSHID:D044342] Infection[MeSHID:D007239] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Immunologic Deficiency Syndromes[MeSHID:D007153] |
NA | approved | metabolizer |
| click here to return to the previous page | ||||||||